Published in Lancet on April 12, 1975
A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet (2002) 2.41
Current status of zinc in health and disease states. Arch Dis Child (1979) 1.78
The Paneth cell. Gut (1979) 1.32
Krüppel-like factor 4 regulates adaptive expression of the zinc transporter Zip4 in mouse small intestine. Am J Physiol Gastrointest Liver Physiol (2009) 1.05
Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3. Am J Hum Genet (2001) 0.97
Metallothionein--aspects related to copper and zinc metabolism. J Inherit Metab Dis (1983) 0.95
Zinc and di-iodohydroxyquinoline therapy in acrodermatitis enteropathica. J Clin Pathol (1977) 0.76
Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids. J Nucl Med (1991) 2.07
Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob Agents Chemother (1997) 1.99
Beta-oxidation of 1-[14C]-17-[131I]-iodo-heptadecanoic acid following intracoronary injection in humans results in similar release of both tracers. Eur J Nucl Med (1993) 1.95
Vitamin A supplementation in malnourished Sudanese children. Int J Vitam Nutr Res (1991) 1.95
Comparison of DNA fingerprint patterns of isolates of Mycobacterium africanum from east and west Africa. J Clin Microbiol (1997) 1.88
Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism. J Pediatr (1997) 1.76
Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol (1993) 1.71
A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov. J Clin Microbiol (1997) 1.52
The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction. J Nucl Med (1991) 1.51
Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr (1984) 1.47
Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain (1990) 1.44
Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta (1976) 1.44
Body growth in primary de Toni-Debré-Fanconi syndrome. Pediatr Nephrol (1997) 1.44
Radiation hormesis. Its emerging significance in medical practice. Invest Radiol (1993) 1.43
[On phenylketonuria. Carrying out of phenylalanine-low diet]. Dtsch Med Wochenschr (1967) 1.42
Noninvasive assessment of regional cardiac adenosine using positron emission tomography. J Nucl Med (1992) 1.41
Glutaryl-coenzyme A dehydrogenase deficiency: a distinct encephalopathy. Pediatrics (1991) 1.41
Radiosensitivity of the colony-forming cells of the mouse bone marrow. Proc Soc Exp Biol Med (1970) 1.38
Cervical lymphadenitis in a child caused by a previously unknown mycobacterium. J Infect Dis (1993) 1.35
Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest (1999) 1.35
The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med (1993) 1.35
Iodine-125, a tracer in cell biology: physical properties and biological aspects. Phys Med Biol (1970) 1.28
Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997. Eur J Pediatr (1999) 1.17
Neurological outcome in adult patients with early-treated phenylketonuria. Eur J Pediatr (1998) 1.17
Transmission dynamics of tuberculosis in a high-incidence country: prospective analysis by PCR DNA fingerprinting. J Clin Microbiol (1999) 1.12
Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr (1990) 1.10
[In-vivo-examinations of the relative radiosensitivity of hypoxic tumor cells (author's transl)]. Strahlentherapie (1977) 1.08
Biologic responses to low doses of ionizing radiation: Detriment versus hormesis. Part 2. Dose responses of organisms. J Nucl Med (2001) 1.07
Inactivation of mammalian cells after disintegration of 3H or 125I in cell DNA at -196 degrees C. Int J Radiat Biol Relat Stud Phys Chem Med (1973) 1.06
Nutrient intake and food consumption of adolescents and young adults with phenylketonuria. Acta Paediatr (1995) 1.06
The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine disease. Eur J Pediatr (1978) 1.04
Changed pattern of regional glucose metabolism during yoga meditative relaxation. Neuropsychobiology (1991) 1.04
Physiological thymidine reutilization in rat bone marrow. Proc Soc Exp Biol Med (1966) 1.03
Intracellular stimulation of biochemical control mechanisms by low-dose, low-LET irradiation. Health Phys (1987) 1.02
Alpha-ketoadipic aciduria: degradation studies with fibroblasts,. Clin Chim Acta (1975) 1.02
Trace element concentration in human brain. Activation analysis of cobalt, iron, rubidium, selenium, zinc, chromium, silver, cesium, antimony and scandium. Brain (1975) 1.01
An alternative to absorbed dose, quality, and RBE at low exposures. Radiat Res Suppl (1985) 0.99
Alpha-ketoadipic aciduria, a new inborn error of lysine metabolism; biochemical studies. Clin Chim Acta (1975) 0.99
Cell-oriented alternatives to dose, quality factor, and dose equivalent for low-level radiation. Health Phys (1990) 0.98
Fat content and fatty acid composition of infant formulas. Acta Paediatr Scand (1989) 0.97
Differences in reutilization of thymidine in hemopoietic and lymphopoietic tissues of the normal mouse. Cell Tissue Kinet (1973) 0.97
Tolerance of phenylalanine after ntravenous administration in phenylketonurics, heterozygous carriers, and normal adults. Nature (1966) 0.95
Biological damage from the Auger effect, possible benefits. Radiat Environ Biophys (1975) 0.95
Fatty acid and lipid composition of children's food. I. Analytical methods; composition of commercially available supplementary foods for juniors. Z Ernahrungswiss (1984) 0.95
Cellular and nuclear volume of human cells during the cell cycle. Radiat Environ Biophys (1981) 0.93
Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr (1996) 0.93
Proliferation kinetics of early hemopoietic precursor cells with self sustaining capacity in the mouse, studied with 125-I-labeled iodo-deoxyuridine. Exp Hematol (1979) 0.92
Notions about human stem cells. Nouv Rev Fr Hematol Blood Cells (1976) 0.92
3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med (1997) 0.92
Molecular biology, epidemiology, and the demise of the linear no-threshold (LNT) hypothesis. C R Acad Sci III (1999) 0.91
Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants. Eur J Pediatr (1989) 0.90
Survival time in cystinosis. A collaborative study. Proc Eur Dial Transplant Assoc (1983) 0.90
What is a 'low dose' of radiation? Int J Radiat Biol Relat Stud Phys Chem Med (1988) 0.90
An assay for the measurement of residual damage of murine hematopoietic stem cells. Exp Hematol (1981) 0.90
Neurological manifestations of organic acid disorders. Eur J Pediatr (1994) 0.89
Fatty acid composition of mature human milk in Germany. Am J Clin Nutr (1988) 0.89
Kinetics of 14(R,S)-fluorine-18-fluoro-6-thia-heptadecanoic acid in normal human hearts at rest, during exercise and after dipyridamole injection. J Nucl Med (1994) 0.89
Tomographic studies of rCBF with [99mTc]-HM-PAO SPECT in patients with brain tumors: comparison with C15O2 continuous inhalation technique and PET. J Cereb Blood Flow Metab (1988) 0.89
Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease. Mov Disord (1993) 0.89
Beta cell nesidioblastosis. Eur J Pediatr (1978) 0.89
Model identification and estimation of organ-function parameters using radioactive tracers and the impulse-response function. Eur J Nucl Med (1985) 0.88
Serum-selenium concentrations in patients with maple-syrup-urine disease and phenylketonuria under dieto-therapy. Clin Chim Acta (1975) 0.88
Cortical activation in profoundly deaf patients during cochlear implant stimulation demonstrated by H2(15)O PET. J Comput Assist Tomogr (1991) 0.88
Reutilization of 5- 125 I-iodo-2'-deoxyuridine and 3 H-thymidine in regenerating liver of mice. Proc Soc Exp Biol Med (1971) 0.88
Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med (1994) 0.88
Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency. J Pediatr (1993) 0.87
Fatty acid composition of plasma lipids in Nigerian children with protein-energy malnutrition. Eur J Pediatr (1986) 0.87
Influence of n-6 and n-3 polyunsaturated fatty acids on the resistance to experimental tuberculosis. Metabolism (1997) 0.87
Selective delivery of liposome-associated cis-dichlorodiammineplatinum(II) by heat and its influence on tumor drug uptake and growth. Cancer Res (1981) 0.87
Two cases of phosphoenolpyruvate carboxykinase deficiency. Acta Paediatr Scand (1976) 0.87
The excretion of diamines in human urine. II. Cadaverine, putrescine, 1,3-diaminopropane, 2,2'-dithiobis(ethylamine) and spermidine in urine of patients with cystinuria and cystinlysinuria. Clin Chim Acta (1971) 0.87
Mathematical modelling in nuclear medicine. Eur J Nucl Med (1991) 0.86
Elemental composition of platelets. Part III. Determination of Ag, Au, Cd, Co, Cr, Cs, Mo, Rb, Sb, and Se in normal human platelets by neutron activation analysis. Clin Chem (1979) 0.86
Propionyl-CoA carboxylase deficiency with overflow of metabolites of isoleucine catabolism at all levels. Eur J Pediatr (1979) 0.86
Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. J Inherit Metab Dis (1998) 0.85
Comparison of the protein quality of dietetically treated phenylketonuria patients with the recommendations of the WHO Expert Consultation. Eur J Pediatr (1996) 0.85
Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria). Eur J Pediatr (1986) 0.85
[Prenatal diagnosis of glycogenosis type II (Pompe) and subsequent therapeutic abortion (author's transl)]. Dtsch Med Wochenschr (1974) 0.85
Vacuolated lymphocytes in type II glycogenosis--a diagnostic approach? Eur J Pediatr (1977) 0.85
Hypercalcemia in hyperthyroidism. Role of age and goiter type. Klin Wochenschr (1981) 0.85
Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr (2000) 0.85
5-Oxoprolinase deficiency associated with severe psychomotor developmental delay, failure to thrive, microcephaly and microcytic anaemia. J Inherit Metab Dis (1995) 0.84
Growth and skeletal maturation in children with phenylketonuria. Acta Paediatr (1994) 0.84
The selenium state of healthy children. I. Serum selenium concentration at different ages; activity of glutathione peroxidase of erythrocytes at different ages; selenium content of food of infants. Eur J Pediatr (1977) 0.84
Influence of dietary (n-3)-polyunsaturated fatty acids on leukotriene B4 and prostaglandin E2 synthesis and course of experimental tuberculosis in guinea pigs. Infection (1994) 0.84
[Possibilities of calculating the fat-free body mass and its reaction to a carbohydrate-poor, fat-rich diet]. Infusionsther Klin Ernahr (1979) 0.84
Facts and artefacts in mevalonic aciduria: development of a stable isotope dilution GCMS assay for mevalonic acid and its application to physiological fluids, tissue samples, prenatal diagnosis and carrier detection. Clin Chim Acta (1991) 0.84
Development of DNA-based radiopharmaceuticals carrying Auger-electron emitters for anti-gene radiotherapy. Q J Nucl Med (2000) 0.83
[Analysis of di- and polyamines in urine. A chromatographic method for concentration, separation and identification]. J Chromatogr (1966) 0.83
A microdosimetric interpretation of the radiobiological effectiveness of 125I and the problem of quality factor. Radiat Environ Biophys (1987) 0.83
Glucose transport and utilization in the human brain: model using carbon-11 methylglucose and positron emission tomography. J Nucl Med (1986) 0.83
Modification of effects of radiation on thymidine kinase. Int J Radiat Biol (1990) 0.82
3-Methylglutaconic aciduria in a patient with Pearson syndrome. Eur J Pediatr (1993) 0.82
Incorporation of thymidine and iododeoxyuridine into the DNA of mouse tissues. Can J Physiol Pharmacol (1975) 0.82
Influence of size of regions of interest on PET evaluation of caudate glucose consumption. J Comput Assist Tomogr (1992) 0.81
Intranuclear 3H thymidine: dosimetric, radiobiological and radiation protection aspects. Health Phys (1966) 0.81
Selenium content of human milk, cow's mild and cow's milk infant formulas. Eur J Pediatr (1978) 0.81